This topic contains a solution. Click here to go to the answer

Author Question: Which of the following conditions would an expectorant drug such as guaifenesin treat effec-tively? ... (Read 67 times)

K@

  • Hero Member
  • *****
  • Posts: 608
Which of the following conditions would an expectorant drug such as guaifenesin treat effec-tively?
 
  a. Acute bronchitis
  b. Asthma
  c. Smoker's cough
  d. Emphysema

Question 2

A younger patient with cystic fibrosis has a new drug order for dornase alpha (Pulmozyme). The health care provider should choose which route of administration for this medication?
 
  a. Oral
  b. Subcutaneous
  c. Inhalation via nebulizer
  d. Rectal



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Tabitha_2016

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

ANS: A
Expectorants such as guaifenesin are most effective in managing symptoms associated with upper respiratory infections such as bronchitis, pharyngitis, and a number of others.

Answer to Question 2

ANS: C
Dornase alpha is an expectorant drug that is used to reduce the incidence of respiratory infections and improve pulmonary function in patients with cystic fibrosis. It is administered once daily via aerosol mist using a compressed air nebulizer.




K@

  • Member
  • Posts: 608
Reply 2 on: Jul 23, 2018
:D TYSM


bbburns21

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library